查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2138124

抗菌和感染控制產品市場預測至2034年—按產品類型、分銷管道、應用、最終用戶和地區分類的全球分析

Antimicrobial & Infection Control Products Market Forecasts to 2034 - Global Analysis By Product Type, Distribution Channel, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，預計到 2026 年，全球抗菌和感染控制產品市場規模將達到 289 億美元，並在預測期內以 5.8% 的複合年成長率成長，到 2034 年將達到 453 億美元。

抗菌和感染控制產品是指在醫療保健、商業、家庭和工業環境中用於最大限度減少、預防和控制有害微生物傳播的各種解決方案。此類別包括消毒劑、抗菌劑、抗菌塗層、清潔產品、滅菌技術、防護設備和衛生解決方案。這些產品透過抑製表面、醫療設備、手部和高頻接觸表面上的微生物，有助於維持更清潔的環境。人們對衛生標準、感染預防和污染控制的日益關注，推動了抗菌和感染控制產品在各種應用中的廣泛使用。

根據世界衛生組織（世衛組織）的數據，每 100 名入院接受急性照護的患者中，高所得國家有 7 名，中低收入國家有 15 名在住院期間至少發生一次醫療保健相關感染（HAI），這凸顯了對感染預防和控制產品的持續需求。

人們越來越關注預防醫療相關感染

對控制醫療相關感染的日益重視推動了抗菌和感染控制產品的應用。醫院、診所、檢查室和長期照護機構對消毒劑、乾洗手劑、無菌溶液、抗菌塗層和防護工具的使用量都在增加。感染預防措施的加強和衛生意識的提高促使各機構改善衛生和污染控制。保護患者、醫護人員和訪客免受有害微生物侵害這一持續優先事項，並不斷推動整體醫療保健領域對高效抗菌和感染控制解決方案的需求。

嚴格的監管要求

嚴格的監管標準會導致研發成本增加、產品上市時間延長，可能會限制抗菌和感染控制產品市場的成長。消毒劑、滅菌液、抗菌塗層及相關技術等產品通常需要進行測試，以確認其安全性、性能和合規性。製造商在產品進入目標市場之前，可能還需完成額外的檢驗程序、文件要求和品質評估。這些要求增加了企業的成本，對中小型製造商的市場准入構成挑戰，並可能延緩創新，限制其在特定應用領域的拓展。

先進抗菌技術的發展

抗菌技術的進步正在為抗菌和感染控制產品市場創造新的成長機會。各公司正致力於開發性能較佳的消毒劑，以增強微生物控制能力，並研發持久耐用的抗菌塗層、表面處理劑及其他解決方案。材料工程和配方技術的進步有助於提升產品性能、增強產品耐久性，並使其在各種應用領域更具通用性。這些創新將推動醫院、食品加工廠、職場、交通和工業設施等領域的應用。持續的研發投入將進一步拓展產品系列，並創造更廣闊的市場機會。

抗菌素抗藥性微生物的出現

抗菌素抗藥性的日益普遍對抗菌和感染控制產品市場構成潛在威脅。這是因為抗藥性微生物的存在會限制現有抗菌方案的療效。應對抗藥性微生物可能需要更複雜的感染預防措施，尤其是在醫療機構。因此，企業可能需要持續投資於新的配方、技術和抗菌機制，以應對不斷演變的微生物所帶來的挑戰。研發投入的增加會導致成本上升，並帶來產品療效、合規性、市場接受度以及在各種感染控制應用中的永續使用的不確定性。

新型冠狀病毒（COVID-19）的影響：

新冠疫情期間，隨著醫院、職場、商業設施和家庭實施更嚴格的衛生措施，對抗菌和感染控制產品的需求顯著增加。隨著各機構集中精力控制病毒傳播，消毒劑、乾洗手劑、防護工具和無菌溶液的消耗量也隨之增加。醫護人員也加強了感染預防措施，以保護病患和醫護人員。雖然疫情結束後，某些與疫情相關的產品需求有所下降，但人們對衛生、微生物污染和預防性衛生措施的認知卻持續存在，並且在各種醫療和非醫療環境中繼續推廣使用這些產品。

在預測期內，消毒劑和乾洗手劑細分市場預計將佔據最大的市場佔有率。

由於消毒劑和乾洗手劑在醫療保健、商業、工業和家庭領域的廣泛應用，預計在預測期內，這類產品將佔據最大的市場佔有率。這些產品通常用於手部、物體表面、設備、職場和高接觸區域，以控制微生物污染並保持衛生。醫院、診所、實驗室、食品加工廠、辦公室和家庭都經常使用這些產品進行衛生管理。多種配方可供選擇，適用於不同的表面、環境和清潔需求，這也進一步促進了該領域的廣泛應用。

在預測期內，醫療保健服務提供者細分市場預計將呈現最高的複合年成長率。

在預測期內，隨著感染預防、病人安全和污染控制在醫療機構中日益重要，醫療服務提供者細分市場預計將呈現最高的成長率。醫院、診所、診斷中心和實驗室對消毒劑、滅菌設備、防護產品和其他感染控制解決方案的需求日益成長。醫療基礎設施的擴建和感染預防規程的加強正在推動這些產品的普及。人們對醫療相關感染的認知不斷提高，加上對現代化醫療設施和先進感染控制技術的投資，預計將繼續支持醫療服務提供者的需求，並進一步促進市場成長。

市佔率最大的地區：

在預測期內，北美地區預計將佔據最大的市場佔有率，這主要得益於其完善的醫療保健體系、成熟的衛生標準以及對感染預防日益成長的重視。消毒劑、滅菌技術、防護屏障、抗菌塗層及相關耗材在醫院及其他醫療機構中廣泛使用。健全的法律規範和完善的醫療基礎設施正在推動全部區域產品的普及。此外，成熟的製造商、持續的技術進步以及巨額的醫療保健支出也進一步鞏固了北美作為這些產品區域市場的地位。

複合年成長率最高的地區：

在預測期內，亞太地區預計將呈現最高的複合年成長率，這主要得益於醫療基礎設施的改善、衛生意識的提高以及對感染預防日益重視。醫療機構正在採用更先進的消毒、滅菌、防護和抗菌解決方案來加強污染控制。中國、印度、日本和東南亞地區醫療支出的成長和基礎設施的建設也促進了產品的普及。醫療服務的擴展、感染控制意識的提高以及醫療設施的現代化預計將在整個預測期內維持該地區的快速成長。

免費客製化服務：

所有購買此報告的客戶均可享受以下免費自訂選項之一：

  • 企業概況
    • 對其他市場參與者（最多 3 家公司）進行全面分析
    • 對主要公司進行SWOT分析（最多3家公司）
  • 區域細分
    • 根據客戶要求，我們可以提供主要國家的市場估算和預測，以及複合年成長率（註：需經可行性確認）。
  • 競爭性標竿分析
    • 根據產品系列、地理覆蓋範圍和策略聯盟對領先公司進行基準分析。

目錄

第1章執行摘要

  • 市場概覽及主要亮點
  • 促進因素、挑戰與機遇
  • 競爭格局概述
  • 戰略洞察與建議

第2章：研究框架

  • 研究目標和範圍
  • 相關人員分析
  • 研究假設和限制
  • 調查方法

第3章 市場動態與趨勢分析

  • 市場定義與結構
  • 主要市場促進因素
  • 市場限制與挑戰
  • 投資成長機會和重點領域
  • 產業威脅與風險評估
  • 技術與創新展望
  • 新興市場/高成長市場
  • 監管和政策環境
  • 新冠疫情的影響及復甦前景

第4章：競爭環境與策略評估

  • 波特五力分析
    • 供應商的議價能力
    • 買方的議價能力
    • 替代品的威脅
    • 新進入者的威脅
    • 競爭公司之間的競爭
  • 主要公司市佔率分析
  • 產品基準評效和效能比較

第5章 全球抗菌與感染控制產品市場：依產品類型分類

  • 消毒劑和清潔劑
  • 消毒器
  • 保護屏障
  • 抗菌塗層和材料
  • 感染控制用品

第6章 全球抗菌與感染控制產品市場：依通路分類

  • 醫院藥房
  • 零售藥房
  • 線上平台
  • 直接向醫療機構銷售

第7章 全球抗菌與感染控制產品市場：依應用分類

  • 醫院和診所
  • 製藥和生物技術公司
  • 研究機構和研究設施
  • 食品/飲料加工
  • 家庭和社區

第8章 全球抗菌和感染控制產品市場：按最終用戶分類

  • 醫療服務提供方
  • 工業用戶
  • 學術和研究機構
  • 消費者

第9章 全球抗菌和感染控制產品市場：按地區分類

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 比利時
    • 瑞典
    • 瑞士
    • 波蘭
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 馬來西亞
    • 新加坡
    • 越南
    • 其他亞太國家
  • 南美洲
    • 巴西
    • 阿根廷
    • 哥倫比亞
    • 智利
    • 秘魯
    • 其他南美國家
  • 世界其他地區（RoW）
    • 中東
      • 沙烏地阿拉伯
      • 阿拉伯聯合大公國
      • 卡達
      • 以色列
      • 其他中東國家
    • 非洲
      • 南非
      • 埃及
      • 摩洛哥
      • 其他非洲國家

第10章 戰略市場資訊

  • 工業價值網路和供應鏈評估
  • 空白區域和機會地圖
  • 產品演進與市場生命週期分析
  • 通路、經銷商和打入市場策略的評估

第11章 產業趨勢與策略舉措

  • 併購
  • 夥伴關係、聯盟和合資企業
  • 新產品發布和認證
  • 擴大生產能力和投資
  • 其他策略舉措

第12章：公司簡介

  • 3M Company
  • Steris plc
  • Ecolab Inc.
  • Getinge AB
  • Belimed AG
  • Reckitt Benckiser Group plc
  • B. Braun Melsungen AG
  • Kimberly-Clark Corporation
  • Cardinal Health, Inc.
  • Becton, Dickinson and Company（BD）
  • Ansell Limited
  • Medline Industries, Inc.
  • Paul Hartmann AG
  • Fortive
  • Solventum
  • Metrex Research, LLC
  • Diversey Holdings, Ltd.
  • Sterigenics International LLC
Product Code: SMRC39745

According to Stratistics MRC, the Global Antimicrobial & Infection Control Products Market is accounted for $28.9 billion in 2026 and is expected to reach $45.3 billion by 2034 growing at a CAGR of 5.8% during the forecast period. Antimicrobial & Infection Control Products comprise various solutions used to minimize, prevent, and manage the transmission of harmful microorganisms across healthcare, commercial, household, and industrial settings. The category covers disinfectants, sanitizing agents, antimicrobial coatings, cleaning products, sterilization technologies, protective equipment, and hygiene solutions. These products help maintain cleaner environments by limiting microbial presence on surfaces, medical equipment, hands, and high-contact areas. Growing attention to hygiene standards, infection prevention, and contamination management is supporting wider use of antimicrobial and infection control products across diverse applications.

According to the World Health Organization (WHO), out of every 100 patients in acute-care hospitals, 7 patients in high-income countries and 15 patients in low- and middle-income countries acquire at least one healthcare-associated infection (HAI) during their hospital stay, demonstrating the continuing need for infection prevention and control products.

Market Dynamics:

Driver:

Rising healthcare-associated infection prevention

Increasing emphasis on controlling healthcare-associated infections is supporting the adoption of antimicrobial and infection control products. Healthcare facilities, including hospitals, clinics, laboratories, and long-term care centers, are expanding their use of disinfectants, sanitizers, sterilization solutions, antimicrobial coatings, and protective equipment. Enhanced infection prevention procedures and stronger awareness of hygiene requirements encourage organizations to improve sanitation and contamination control. The ongoing priority of safeguarding patients, medical personnel, and visitors from harmful microorganisms continues to create demand for effective antimicrobial and infection control solutions across healthcare settings.

Restraint:

Stringent regulatory requirements

Strict regulatory standards may limit growth in the Antimicrobial & Infection Control Products Market by raising development expenses and extending commercialization timelines. Products such as disinfectants, sterilization solutions, antimicrobial coatings, and related technologies generally require testing to verify their safety, performance, and regulatory compliance. Manufacturers may also face additional validation procedures, documentation requirements, and quality evaluations before products can enter targeted markets. Such requirements can increase business costs and create entry challenges for smaller manufacturers, potentially delaying innovations and restricting expansion into certain application areas.

Opportunity:

Development of advanced antimicrobial technologies

Advancements in antimicrobial technologies are creating new growth opportunities within the Antimicrobial & Infection Control Products Market. Companies are working on improved disinfectants, durable antimicrobial coatings, treated surfaces, and other solutions that provide enhanced control of microorganisms. Progress in material engineering and formulation techniques can contribute to greater product performance, longevity, and versatility across different applications. Such innovations can encourage adoption in hospitals, food processing facilities, workplaces, transportation systems, and industrial locations. Ongoing research and development can further expand product portfolios and enable wider market opportunities.

Threat:

Emergence of antimicrobial-resistant microorganisms

Increasing antimicrobial resistance represents a potential threat to the Antimicrobial & Infection Control Products Market because resistant microorganisms can limit the performance of some existing antimicrobial solutions. Managing resistant organisms may require more advanced infection prevention approaches, especially within healthcare settings. Companies may therefore need continuous investment in new formulations, technologies, and antimicrobial mechanisms to respond to evolving microbial challenges. Higher research and development requirements can raise costs and create uncertainties concerning product effectiveness, regulatory compliance, market acceptance, and sustained use across different infection control applications.

Covid-19 Impact:

COVID-19 created a strong increase in demand for antimicrobial and infection control products as hospitals, workplaces, commercial facilities, and households adopted stricter sanitation measures. Consumption of disinfectants, hand sanitizers, protective equipment, and sterilization solutions rose as organizations focused on limiting virus transmission. Healthcare providers also reinforced infection prevention protocols to safeguard patients and medical personnel. While demand for certain pandemic-related products declined after emergency conditions diminished, lasting awareness of hygiene, microbial contamination, and preventive sanitation continued encouraging use across diverse healthcare and non-healthcare settings.

The disinfectants & sanitizers segment is expected to be the largest during the forecast period

The disinfectants & sanitizers segment is expected to account for the largest market share during the forecast period because of their extensive use across healthcare, commercial, industrial, and household settings. They are commonly applied to hands, surfaces, equipment, workplaces, and high-contact areas to control microbial contamination and maintain hygiene. Hospitals, clinics, laboratories, food-processing facilities, offices, and homes regularly depend on these products for sanitation purposes. The availability of multiple formulations suited to different surfaces, environments, and cleaning requirements further strengthens the segment's widespread utilization.

The healthcare providers segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the healthcare providers segment is predicted to witness the highest growth rate as healthcare facilities increasingly prioritize infection prevention, patient safety, and contamination control. Hospitals, clinics, diagnostic centers, and laboratories require consistent use of disinfectants, sterilization equipment, protective products, and other infection-control solutions. Expansion of healthcare infrastructure and stronger infection-prevention protocols are encouraging broader adoption of these products. Growing awareness of healthcare-associated infections, combined with investments in modern medical facilities and advanced infection-control technologies, is expected to support continued demand from healthcare providers and strengthen their growth within the market.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, driven by developed healthcare systems, established hygiene standards, and growing emphasis on preventing infections. Hospitals and other healthcare facilities regularly utilize disinfectants, sterilization technologies, protective barriers, antimicrobial coatings, and related consumables. Robust regulatory frameworks and well-developed medical infrastructure support consistent product adoption throughout the region. In addition, the presence of established manufacturers, ongoing technological advancements, and considerable healthcare expenditure strengthen North America's position as the largest regional market for these products.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, driven by improving medical infrastructure, stronger hygiene awareness, and increasing focus on infection prevention. Healthcare facilities are adopting more advanced disinfection, sterilization, protective, and antimicrobial solutions to strengthen contamination control. Rising healthcare expenditure and infrastructure development across China, India, Japan, and Southeast Asia are also encouraging product adoption. Expanding healthcare services, greater infection-control awareness, and modernization of medical facilities are expected to sustain the region's rapid growth throughout the forecast period.

Key players in the market

Some of the key players in Antimicrobial & Infection Control Products Market include 3M Company, Steris plc, Ecolab Inc., Getinge AB, Belimed AG, Reckitt Benckiser Group plc, B. Braun Melsungen AG, Kimberly-Clark Corporation, Cardinal Health, Inc., Becton, Dickinson and Company (BD), Ansell Limited, Medline Industries, Inc., Paul Hartmann AG, Fortive, Solventum, Metrex Research, LLC, Diversey Holdings, Ltd. and Sterigenics International LLC.

Key Developments:

In March 2026, Ecolab announced that it has entered into a definitive agreement to acquire CoolIT Systems, a high-growth, high-margin leader in liquid cooling technology for next-gen AI data centers. CoolIT is expected to generate approximately $550 million in sales over the next 12 months. With CoolIT's rapid sales growth, the acquisition is expected to significantly strengthen the company's Global High-Tech growth engine and accelerate Global Water's organic sales growth rate by 2% and Ecolab's total organic sales growth rate by 1%.

In May 2025, 3M has reached an agreement that resolves all legacy claims related to the Chambers Works site in Salem County, New Jersey, currently owned by The Chemours Company and, before that, by DuPont. In addition, the settlement extends to PFAS-related claims that the State of New Jersey and its departments have, or may in the future have, against 3M.

Product Types Covered:

  • Disinfectants & Sanitizers
  • Sterilization Equipment
  • Protective Barriers
  • Antimicrobial Coatings & Materials
  • Infection Control Consumables

Distribution Channels Covered:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Platforms
  • Direct Institutional Sales

Applications Covered:

  • Hospitals & Clinics
  • Pharmaceutical & Biotechnology Companies
  • Laboratories & Research Facilities
  • Food & Beverage Processing
  • Household & Community Settings

End Users Covered:

  • Healthcare Providers
  • Industrial Users
  • Academic & Research Institutions
  • Consumers

Regions Covered:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Spain
    • Netherlands
    • Belgium
    • Sweden
    • Switzerland
    • Poland
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Thailand
    • Malaysia
    • Singapore
    • Vietnam
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Colombia
    • Chile
    • Peru
    • Rest of South America
  • Rest of the World (RoW)
    • Middle East
  • Saudi Arabia
  • United Arab Emirates
  • Qatar
  • Israel
  • Rest of Middle East
    • Africa
  • South Africa
  • Egypt
  • Morocco
  • Rest of Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

  • 1.1 Market Snapshot and Key Highlights
  • 1.2 Growth Drivers, Challenges, and Opportunities
  • 1.3 Competitive Landscape Overview
  • 1.4 Strategic Insights and Recommendations

2 Research Framework

  • 2.1 Study Objectives and Scope
  • 2.2 Stakeholder Analysis
  • 2.3 Research Assumptions and Limitations
  • 2.4 Research Methodology
    • 2.4.1 Data Collection (Primary and Secondary)
    • 2.4.2 Data Modeling and Estimation Techniques
    • 2.4.3 Data Validation and Triangulation
    • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

  • 3.1 Market Definition and Structure
  • 3.2 Key Market Drivers
  • 3.3 Market Restraints and Challenges
  • 3.4 Growth Opportunities and Investment Hotspots
  • 3.5 Industry Threats and Risk Assessment
  • 3.6 Technology and Innovation Landscape
  • 3.7 Emerging and High-Growth Markets
  • 3.8 Regulatory and Policy Environment
  • 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

  • 4.1 Porter's Five Forces Analysis
    • 4.1.1 Supplier Bargaining Power
    • 4.1.2 Buyer Bargaining Power
    • 4.1.3 Threat of Substitutes
    • 4.1.4 Threat of New Entrants
    • 4.1.5 Competitive Rivalry
  • 4.2 Market Share Analysis of Key Players
  • 4.3 Product Benchmarking and Performance Comparison

5 Global Antimicrobial & Infection Control Products Market, By Product Type

  • 5.1 Disinfectants & Sanitizers
  • 5.2 Sterilization Equipment
  • 5.3 Protective Barriers
  • 5.4 Antimicrobial Coatings & Materials
  • 5.5 Infection Control Consumables

6 Global Antimicrobial & Infection Control Products Market, By Distribution Channel

  • 6.1 Hospital Pharmacies
  • 6.2 Retail Pharmacies
  • 6.3 Online Platforms
  • 6.4 Direct Institutional Sales

7 Global Antimicrobial & Infection Control Products Market, By Application

  • 7.1 Hospitals & Clinics
  • 7.2 Pharmaceutical & Biotechnology Companies
  • 7.3 Laboratories & Research Facilities
  • 7.4 Food & Beverage Processing
  • 7.5 Household & Community Settings

8 Global Antimicrobial & Infection Control Products Market, By End User

  • 8.1 Healthcare Providers
  • 8.2 Industrial Users
  • 8.3 Academic & Research Institutions
  • 8.4 Consumers

9 Global Antimicrobial & Infection Control Products Market, By Geography

  • 9.1 North America
    • 9.1.1 United States
    • 9.1.2 Canada
    • 9.1.3 Mexico
  • 9.2 Europe
    • 9.2.1 United Kingdom
    • 9.2.2 Germany
    • 9.2.3 France
    • 9.2.4 Italy
    • 9.2.5 Spain
    • 9.2.6 Netherlands
    • 9.2.7 Belgium
    • 9.2.8 Sweden
    • 9.2.9 Switzerland
    • 9.2.10 Poland
    • 9.2.11 Rest of Europe
  • 9.3 Asia Pacific
    • 9.3.1 China
    • 9.3.2 Japan
    • 9.3.3 India
    • 9.3.4 South Korea
    • 9.3.5 Australia
    • 9.3.6 Indonesia
    • 9.3.7 Thailand
    • 9.3.8 Malaysia
    • 9.3.9 Singapore
    • 9.3.10 Vietnam
    • 9.3.11 Rest of Asia Pacific
  • 9.4 South America
    • 9.4.1 Brazil
    • 9.4.2 Argentina
    • 9.4.3 Colombia
    • 9.4.4 Chile
    • 9.4.5 Peru
    • 9.4.6 Rest of South America
  • 9.5 Rest of the World (RoW)
    • 9.5.1 Middle East
      • 9.5.1.1 Saudi Arabia
      • 9.5.1.2 United Arab Emirates
      • 9.5.1.3 Qatar
      • 9.5.1.4 Israel
      • 9.5.1.5 Rest of Middle East
    • 9.5.2 Africa
      • 9.5.2.1 South Africa
      • 9.5.2.2 Egypt
      • 9.5.2.3 Morocco
      • 9.5.2.4 Rest of Africa

10 Strategic Market Intelligence

  • 10.1 Industry Value Network and Supply Chain Assessment
  • 10.2 White-Space and Opportunity Mapping
  • 10.3 Product Evolution and Market Life Cycle Analysis
  • 10.4 Channel, Distributor, and Go-to-Market Assessment

11 Industry Developments and Strategic Initiatives

  • 11.1 Mergers and Acquisitions
  • 11.2 Partnerships, Alliances, and Joint Ventures
  • 11.3 New Product Launches and Certifications
  • 11.4 Capacity Expansion and Investments
  • 11.5 Other Strategic Initiatives

12 Company Profiles

  • 12.1 3M Company
  • 12.2 Steris plc
  • 12.3 Ecolab Inc.
  • 12.4 Getinge AB
  • 12.5 Belimed AG
  • 12.6 Reckitt Benckiser Group plc
  • 12.7 B. Braun Melsungen AG
  • 12.8 Kimberly-Clark Corporation
  • 12.9 Cardinal Health, Inc.
  • 12.10 Becton, Dickinson and Company (BD)
  • 12.11 Ansell Limited
  • 12.12 Medline Industries, Inc.
  • 12.13 Paul Hartmann AG
  • 12.14 Fortive
  • 12.15 Solventum
  • 12.16 Metrex Research, LLC
  • 12.17 Diversey Holdings, Ltd.
  • 12.18 Sterigenics International LLC

List of Tables

  • Table 1 Global Antimicrobial & Infection Control Products Market Outlook, By Region (2023-2034) ($MN)
  • Table 2 Global Antimicrobial & Infection Control Products Market Outlook, By Product Type (2023-2034) ($MN)
  • Table 3 Global Antimicrobial & Infection Control Products Market Outlook, By Disinfectants & Sanitizers (2023-2034) ($MN)
  • Table 4 Global Antimicrobial & Infection Control Products Market Outlook, By Sterilization Equipment (2023-2034) ($MN)
  • Table 5 Global Antimicrobial & Infection Control Products Market Outlook, By Protective Barriers (2023-2034) ($MN)
  • Table 6 Global Antimicrobial & Infection Control Products Market Outlook, By Antimicrobial Coatings & Materials (2023-2034) ($MN)
  • Table 7 Global Antimicrobial & Infection Control Products Market Outlook, By Infection Control Consumables (2023-2034) ($MN)
  • Table 8 Global Antimicrobial & Infection Control Products Market Outlook, By Distribution Channel (2023-2034) ($MN)
  • Table 9 Global Antimicrobial & Infection Control Products Market Outlook, By Hospital Pharmacies (2023-2034) ($MN)
  • Table 10 Global Antimicrobial & Infection Control Products Market Outlook, By Retail Pharmacies (2023-2034) ($MN)
  • Table 11 Global Antimicrobial & Infection Control Products Market Outlook, By Online Platforms (2023-2034) ($MN)
  • Table 12 Global Antimicrobial & Infection Control Products Market Outlook, By Direct Institutional Sales (2023-2034) ($MN)
  • Table 13 Global Antimicrobial & Infection Control Products Market Outlook, By Application (2023-2034) ($MN)
  • Table 14 Global Antimicrobial & Infection Control Products Market Outlook, By Hospitals & Clinics (2023-2034) ($MN)
  • Table 15 Global Antimicrobial & Infection Control Products Market Outlook, By Pharmaceutical & Biotechnology Companies (2023-2034) ($MN)
  • Table 16 Global Antimicrobial & Infection Control Products Market Outlook, By Laboratories & Research Facilities (2023-2034) ($MN)
  • Table 17 Global Antimicrobial & Infection Control Products Market Outlook, By Food & Beverage Processing (2023-2034) ($MN)
  • Table 18 Global Antimicrobial & Infection Control Products Market Outlook, By Household & Community Settings (2023-2034) ($MN)
  • Table 19 Global Antimicrobial & Infection Control Products Market Outlook, By End User (2023-2034) ($MN)
  • Table 20 Global Antimicrobial & Infection Control Products Market Outlook, By Healthcare Providers (2023-2034) ($MN)
  • Table 21 Global Antimicrobial & Infection Control Products Market Outlook, By Industrial Users (2023-2034) ($MN)
  • Table 22 Global Antimicrobial & Infection Control Products Market Outlook, By Academic & Research Institutions (2023-2034) ($MN)
  • Table 23 Global Antimicrobial & Infection Control Products Market Outlook, By Consumers (2023-2034) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) Regions are also represented in the same manner as above.